Expression of exogenous wt-p53 in dierent tumor cell lines can induce growth arrest, apoptosis, or dierentiation. Several experimental works have highlighted the relevance of cellular context in the determination of p53-mediated ®nal outcomes. We recently observed that these diverse wt-p53 eects can also be induced by overexpressing wt-p53 in a single cell type ± the 32D myeloid progenitors ± transformed with dierent activated oncogenes. Here we show that 32D cells transformed with two dierent oncogenes, v-src or c-fms [S301,F969], both belonging to the CSF-1 transduction pathway, respond to exogenous wt-p53 expression with the same ®nal outcome ± monocytic dierentiation. This result is particularly signi®cant since 32D cells do not spontaneously express the CSF-1 receptor, whereas they undergo granulocytic dierentiation upon G-CSF stimulation. These data strongly support the idea that wt-p53 suppressing eects result from interactions between p53 activity and the signaling pathways activated in dierent transformed cells.
A large number of experimental works conducted in vitro and in vivo with dierent types of tumors are consistent with the notion that p53 acts as a tumor suppressor (reviewed in Gottlieb and Oren, 1996) . However, the mechanism(s) through which p53 exerts its suppressing activity is still under intense investigation. Recently, the relevance of cellular environment in the determination of p53-mediated events has been highlighted (Canman et al., 1995; Haupt et al., 1996) . In this regard, we had previously observed that exogenous wt-p53 expression can induce dierent eects in a single cell type ± the 32D myeloid progenitors ± transformed with dierent activated oncogenes. The 32D cells are diploid, non-tumorigenic cells (Greenberger et al., 1983a,b; Migliaccio et al., 1989) , with endogenous wt-p53 expressed at low levels (Blandino et al., 1995) . These cells depend on IL-3 for survival and proliferation and dierentiate into granulocytes in the presence of granulocyte-colony stimulating factor (G-CSF) . IL-3 dependence and/or G-CSF responsiveness are lost upon expression of several activated oncogenes Mavilio et al., 1989; Anderson et al., 1990; Kruger and Anderson, 1991; Patel et al., 1993) . We had found that in these cells co-expression of wt-p53 with v-abl results in growth arrest, with v-src in dierentiation, and with v-Ha-ras in acceleration of apoptosis upon IL-3 withdrawal, indicating that the interactions between oncogene-activated pathways and wt-p53 activity can modulate the ®nal outcomes of p53 tumor suppression (Soddu et al., 1996) . Remarkably, the wt-p53 induced dierentiation we observed in the 32Dsrc-transformed cells was through the monocytic pathway. This was a rather surprising result since 32D cells possess the G-CSF receptor and dierentiate into granulocytes upon stimulation with G-CSF , whereas they do not express the c-fms/CSF-1 receptor for macrophage-colony stimulating factor (M-CSF) and do not normally dierentiate into monocytes/macrophages Pierce et al., 1990) . Interestingly, the c-src protein belongs to the signal transduction pathway of c-fms (Courtneidge et al., 1993) . Thus, the monocytic dierentiation observed in 32D cells co-expressing v-src and wt-p53 proteins might be interpreted as wt-p53-induced restoration of the dierentiation capacity of transformed cells. Expression of wt-p53 would allow the use of the abnormal v-src signal to induce the type of eect in which the proto-oncogene is involved (i.e., monocyte/ macrophage dierentiation). If this hypothesis is correct, it would strongly support the idea that wtp53 suppressing eects are the results of interactions between p53 action and the signaling pathways which are activated in dierent transformed cells.
It has been reported that transfection of 32D cells with a constitutively activated CSF-1 receptor ± the c-fms [S301,F969] ± induces IL-3-independence and tumorigenicity (Pierce et al., 1990) . We wished to clarify whether p53 has a suppressive action which produces dierent ®nal outcomes depending on the pathways activated by the transforming oncogenes. To this aim, we evaluated the eects induced by exogenous wt-p53 expression in 32D cells transformed by two dierent oncogenes belonging to the same transduction pathway (i.e., c-fms[S301,F969] and v-src). Exogenous wt-p53 expression was induced in 32D-fms[S301,F969] cells by transfection of the temperature-sensitive p53Val 135 (tsp53) mutant (Michalovitz et al., 1990) , or by infection with the recombinant retrovirus Lp53SN obtained by cloning the human wt-p53 into the pLXSN vector (Miller and Rosman, 1989) . Cells clones (32Dfms-tsp53#3 and 32Dfms-neo#1 as control) were obtained by limiting dilution from the transfection of tsp53-and neo-carrying vectors. To avoid clone-dependent artifacts, cells infected with Lp53SN or LXSN as control, were maintained as polyclonal populations. Expression of exogenous p53 was assessed by Western blotting (Figure 1 ). 32D-src cells transfected with the tsp53 vector (32Dsrc-tsp53#10), or infected with the wt-p53 retrovirus (32Dsrc-Lp53) were described elsewhere (Soddu et al., 1996; Scardigli et al., submitted) . These cells express exogenous p53 protein at levels comparable to those obtained in 32Dfms [S301,F969] cells (not shown).
To study the tumor-suppressor activity of wt-p53 overexpression we evaluated cell viability, proliferation, and dierentiation of our p53-transduced 32Dfms-transformed cells, and compared these results with those previously obtained with 32Dsrc-transformed cells. Cell viability curves, obtained by trypan blue exclusion, showed that 32Dfms-tsp53#3 incubated at 328C and the 32Dfms-Lp53 cultured at 378C, both in the absence of IL-3, survived as well as control cells (Figure 2a ).
Proliferation was determined by counting every other day the numbers of live cells in the presence of trypan blue. A reduced rate of proliferation was observed in the 32Dfms-tsp53#3 clone maintained at 328C (Figure 2b ). However, these cells did not stop dividing, as cell cycle analysis showed only a slight increase in the percentage of cells in the G1 phase ( Table 1) . No dierence was observed between 32D-Lp53 and 32D-LX control cells (Figure 2b ). These data
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Interactions between wt-p53 and cell environment R Martinelli et al indicate that, at least at the levels of exogenous wt-p53 expressed, 32Dfms[S301,F969] cells do not respond to wt-p53 overexpression by undergoing apoptosis or growth arrest. A similar behavior was previously observed in wt-p53-expressing 32Dsrc-transformed cells (Soddu et al., 1996) . 32D-fms[S301,F969] cells, despite their IL-3-independence and in vivo tumorigenicity, were originally reported to have a partially dierentiated monocytic phenotype (Pierce et al., 1990) . When morphology was assessed by direct observation of fresh cultures and by May-Grunwald Giemsa staining, after induction of wt-p53 overexpression, we did not ®nd any further maturation into adherent macrophages (Figure 4 (Soddu et al, 1996) . This dierence between 32Dfms[S301,F969]-and 32Dsrc-transformed cells might depend on the more speci®c signal of the activated CSF-1 receptor, compared to the src protein.
Consistently with the morphological data, 32D-fms [S301,F969] cells express higher levels of the CD11b and F4-80 monocyte/macrophage cell surface antigens (Larson and Springer, 1990; Austiyn and Gordon, 1981; Hume et al., 1983 ) than 32D-src cells (1.7-fold for CD11b, and 3.6-fold for F4-80). Wt-p53 over- expression was able to increase the levels of these two antigens in 32D-src cells after four days of incubation at the permissive temperature (1.9-fold for CD11b, and 1.4-fold for F4-80), while no signi®cant increase was found in the 32Dfms-transformed cells, even after 10 days of incubation at the permissive temperature (1.2-fold for CD11b and 0.9-fold for F4-80), or 3 weeks post-infection (1.06-fold for CD11b and 1.08-fold for F4-80). Indeed, in 32Dfms[S301,F969] cells a further, slight increase in the expression levels of CD11b, but not F4-80, was only observed after TPAinduced terminal dierentiation into macrophages (1.3-fold for CD11b and 1.2-fold for F4-80). The monocytic dierentiation induced by wt-p53 overexpression in 32D-src cells was originally demonstrated by morphology and histochemical analysis for a-naphthyl butyrate esterase (NBE), which is a speci®c marker of lympho-monocytic dierentiation. Despite the dierences in morphology and CD11b and F4-80 antigen expression, we found that NBE is absent in both 32D-src and 32D-fms[S301,F969] cells (Figure 3a and b). Overexpression of wt-p53 strongly induced NBE positivity (Figure 3a and b) , indicating that p53 can promote further maturation through the monocytic pathway also in the partially dierentiated 32D-fms[S301,F969] cells. Red-brown stained, NBE-positive cells began to be evident among 32Dfms-tsp53#3 cells after 4 days of incubation at the permissive temperature of 328C (Figure 3c ). No spontaneous dierentiation was observed in 32Dfms-neo#1 cells at the same temperature, or in any of the cell lines incubated at 378C (Figure 3a) . NBE positivity was also found in 32Dfms-Lp53 cells after approximately 3 weeks from wt-p53-recombinant retrovirus infection, whereas the control 32Dfms-LX remained negative (Figure 3d) . Surprisingly, 32Dfms-Lp53 cells became NBE-positive 3 weeks after infection. This result was obtained repeatedly with cells from two dierent infections. Since the low temperature that is permissive for the tsp53 protein reduces cell metabolism and proliferation, we asked whether these factors could in some way be responsible of the dierent times required by the two types of p53-transduced cells to dierentiate. To verify this possibility we incubated the 32Dfms-Lp53 cells at 328C and assessed NBE expression twice a week. No acceleration of the appearance of NBE-positivity was observed (not shown). Despite the absence of a de®nitive explanation for the delayed dierentiation, this phenomenon does not appear to be a casual one. We obtained a similar discrepancy between tsp53-and Lp53SN-transduced cells in 32D-src (not shown) and HL-60 cell lines (Rizzo et al., submitted). 32D cell responsiveness to G-CSF is one of the ®rst characteristics which are lost after expression of activated oncogenes such as v-src (Kruger and Anderson, 1991) . Since exogenous wt-p53 expression was reported to be able to restore cytokine responsiveness, we asked whether incubation of wt-p53-expressing 32Dsrc-and 32Dfms[S301,F969]-transformed cells in the presence of G-CSF, the physiological dierentiation stimulus for parental 32D cells, would shift dierentiation to the granulocytic pathway. For this purpose, 32Dsrc-tsp53#10, 32Dfms-tsp53#3, and related controls (32Dsrc-puro#1, and 32Dfms-neo#1) were incubated at 328C in the presence of G-CSF for 2 weeks. In contrast to parental 32D cells, more than 80% of which acquired the polymorphonucleated morphology, none of the other cell types dierentiated into granulocytes (Figure 4) . Actually, as observed in the absence of any cytokine, monocytic maturation was observed in 32Dsrc-tsp53#10 cells. Moreover, NBE analysis was positive in both 32Dsrc-tsp53#10 and 32Dfms-tsp53#3 cells (not shown). G-CSF can promote both proliferation and differentiation. To evaluate whether unresponsiveness of 32Dsrc-and 32Dfms[S301,F969]-transformed cells to G-CSFinduced dierentiation was due to loss of G-CSF receptor function, we evaluated whether incubation of these cells in the presence of G-CSF stimulates their proliferation. Increased proliferation rates were observed in both 32Dsrc-tsp53#10 and 32Dfms-tsp53#3 cells upon incubation at 328C in the presence of G-CSF. The duplication times were 123 h and 185 h, respectively, in the absence and the cytokine and 73 h and 68 h in the presence of G-CSF, indicating that the G-CSF receptor is present and transduces at least
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Figure 4 Morphological analysis. Cytospin preparations of the indicated cells were stained by May ± Grunwald Giemsa. Before morphological analysis the cells were maintained at 328C for 2 weeks in the absence or presence of conditioned medium from the human glioblastoma cell line U87MG as a source of crude G-CSF (Mavilio et al., 1989) to induce granulocytic dierentiation. Parental 32D cells, that in absence of G-CSF were maintained in the presence of IL-3, became polymorphonucleated in the presence of G-CSF. No dierentiation was observed in the 32Dfms-neo#1 and 32Dsrc-puro#1 control cells after addition of G-CSF. In contrast, monocytic morphology was observed in 32Dfms-tsp53#3 and 32Dsrc-tsp53#10 cells both in the presence and absence of G-CSF proliferation stimuli. These results show that the M-CSF/CSF-1 receptor pathway activated by oncogenes such as c-fms[S301,F969] or v-src can prevail over the physiologically activated G-CSF receptor pathway, even in the presence of exogenous wt-p53 protein.
Thus, it can be speculated that, at least for the activated fms and src oncogenes, wt-p53 suppressing activity is not due to inactivation of these oncogenes, but rather to a modi®cation of their ®nal eects ± dierentiation instead of transformation.
In conclusion, the results reported suggest that p53 normalizes the transformed phenotype without completely suppressing the oncogene activated pathways involved in cell transformation. The molecular mechanism(s) involved in this modi®cation are unknown. It can be speculated that wt-p53 overexpression might subtract important co-factors to the transforming side of the oncogene activated pathways by inducing p21 up-regulation (El-Deiry et al., 1993) , and/or binding transcription factors such as E2F/DP1 (Hiebert et al., 1995; Sorensen et al., 1996) . We have previously shown that, despite determining dierent ®nal phenotypes, wt-p53 overexpression induces p21 Waf1 up-regulation in 32D cells transformed with dierent oncogenes (Soddu et al., 1996) . However, we currently do not know how and whether this p21 WAF1 upregulation is related to the oncogene pathway modi®cations we observe.
